S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
Status:
Withdrawn
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using
goserelin and anastrozole may fight breast cancer by blocking the use of estrogen by the
tumor cells. Giving goserelin together with anastrozole may be an effective treatment for
male breast cancer.
PURPOSE: This phase II trial is studying how well giving goserelin together with anastrozole
works in treating men with recurrent or metastatic breast cancer.